Mirati Therapeutics downgraded to Market Carry out from Outperform at BMO Capital

Earlier Put up

Mirati Therapeutics worth goal lowered to $84 from $110 at Piper Sandler

Subsequent Put up

MedTech Acquisition Company Pronounces Adjournment of its Particular Assembly in lieu of an Annual Assembly of Stockholders

Supply hyperlink

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button